Please Sign Up for Weekly Newsletter of Beautiful Lands!

Preparatory Division String Camp, June 20-24, Ages 6-9 and 9-12. Registration deadline is May 20th. Preparatory Division, Tanner Dance and Youth Theatre Arts Passport, June 27 - July 1, Create an original performance work to be presented at the Tanner Dance Building. Preparatory Division International Piano Festival, July 26 - July 29, Musicianship, ukulele, and choir classes. University of Utah, School of Music.

Home in Their Eyes: Images and Stories of Home by Residents in Rural China, Friday, March 25 – Thursday, June 2, 2016, J. Willard Marriott Library 3rd Floor

Salt Dance Fest 2016 brings together internationally renowned dance artists and dance makers Jeanine Durning, Alex Ketley and Jennifer Nugent, along with esteemed SLC dance artists Daniel Charon, Molly Heller and Stephen Koester for two weeks of moving, collaborating, dance making and the lively exchange of ideas, June 6-17, 2016.

Summer Chamber Music Workshop, Matt Zalkind, June 26 - 30, 2016, Hasse Borup, Director, Open for serious string and piano players, age 12 - 26,  School of Music, University of Utah

University of Utah Department of Ballet Summer Intensive, June 20 - July 15, 2016. Join us for an exciting four-week ballet intensive with internationally recognized faculty and guest artists.

Performance Calendar of 2015 - 2016 Season, Department of Ballet, University of Utah

Performance Calendar of 2015 - 2016 Season, Department of Modern Dance, University of Utah

Natural History Museum of Utah 2015 Lecture Series

College of Fine Arts, University of Utah

Remarkable Results of New Cancer Treatment

‘This is unprecedented’ says researcher after more than half of terminally ill blood cancer patients experienced complete remission in early clinical trials. Scientists are claiming “extraordinary” success with engineering immune cells to target a specific type of blood cancer in their first clinical trials.

Among several dozen patients who would typically have only had months to live, early experimental trials that used the immune system’s T-cells to target cancers had “extraordinary results”.

In one study, 94% of participants with acute lymphoblastic leukaemia (ALL) saw symptoms vanish completely. Patients with other blood cancers had response rates greater than 80%, and more than half experienced complete remission.

Speaking at the annual meeting for the American Association for the Advancement for Science (AAAS), researcher Stanley Riddell said: “This is unprecedented in medicine, to be honest, to get response rates in this range in these very advanced patients.”

More Coverage

Posts Archives